Journal
METABOLIC BRAIN DISEASE
Volume -, Issue -, Pages -Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11011-023-01196-5
Keywords
Stellate ganglion block; Cerebral ischemia-reperfusion injury; Ferroptosis; Hippo pathway
Categories
Ask authors/readers for more resources
This study aimed to investigate the effects of stellate ganglion block (SGB) on cerebral ischemia-reperfusion (I/R) injury. The results showed that SGB inhibited ferroptosis of hippocampal neurons via activating the Hippo pathway, thereby alleviating I/R injury. These findings provide a new insight into the treatment of ischemic stroke and other ischemic encephalopathies.
Ischemic stroke is a disabling and fatal disease caused by the insufficient blood supply to the brain. Stellate ganglion block (SGB) is a type of anesthesia commonly used to relieve pain. Here, we sought to identify the effects of SGB on cerebral ischemia-reperfusion (I/R) injury. The middle cerebral artery occlusion (MCAO) model was established in rats. The brain injury was assessed using the 2,3,5-triphenyl-tetrazolium-chloride (TTC) staining assay and neurological score. Ferroptosis was analyzed by detecting cell death, Fe2+ content, glutathione (GSH), malonic dialdehyde (MDA), superoxide dismutase (SOD), and ferroptosis-related factors. The mechanisms of SGB were assessed using the western blot. The results showed that I/R increased brain infarction and damaged neurological function. SGB decreased I/R-induced infarction and improved neurological function. Meantime, SGB inhibited ferroptosis of the hippocampus induced by I/R via the Hippo pathway. and the Yes1 associated transcriptional regulator (YAP) of this pathway was positively correlated with the ferroptosis-related solute carrier family 7 member 11 (SLC7A11). Inhibition of the Hippo pathway reversed the effects of SGB on brain injury and ferroptosis. In conclusion, SGB inhibited ferroptosis of hippocampal neurons via activating the Hippo pathway and thereby alleviated I/R injury. The data provide a novel insight into the treatment of ischemic stroke and even other ischemic encephalopathies.[GRAPHICAL ABSTRACT}
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available